药代-话题@MedSci

#药代#

158篇内容 | 1620人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1666747, encodeId=22b11666e477c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=央视曝光！一批医药代表被抓, objectType=article, longId=182171, objectId=b9ef1821e1eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9ef1821e1eb, replyNumber=0, likeNumber=35, createdTime=2020-04-09, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9ef1821e1eb, moduleTitle=央视曝光！一批医药代表被抓, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9ef1821e1eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666740, encodeId=3a521666e404d, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=全国4+7后，医药代表要跳槽了, objectType=article, longId=178931, objectId=d8391e893154, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8391e893154, replyNumber=0, likeNumber=28, createdTime=2020-08-01, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8391e893154, moduleTitle=全国4+7后，医药代表要跳槽了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8391e893154)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666737, encodeId=efcf1666e3734, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医药代表迎生死局亟待转型, objectType=article, longId=177791, objectId=49711e779155, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49711e779155, replyNumber=0, likeNumber=17, createdTime=2020-05-03, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49711e779155, moduleTitle=医药代表迎生死局亟待转型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49711e779155)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666725, encodeId=567b1666e25dc, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=暗访印度药代购聊城“假药”案的卡博替尼还真是“假药”, objectType=article, longId=161448, objectId=f4dc161448a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4dc161448a1, replyNumber=0, likeNumber=24, createdTime=2020-02-09, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4dc161448a1, moduleTitle=暗访印度药代购聊城“假药”案的卡博替尼还真是“假药”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4dc161448a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666722, encodeId=b9ec1666e222f, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=药代离职率高居不下 70%准备转型, objectType=article, longId=161021, objectId=a9b616102116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9b616102116, replyNumber=0, likeNumber=26, createdTime=2019-05-22, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9b616102116, moduleTitle=药代离职率高居不下 70%准备转型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9b616102116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666741, encodeId=4a721666e4187, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=便民服务：全国很大的医院煎药中心正式启用，中药代煎送药到家, objectType=article, longId=179707, objectId=371b1e9707a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=371b1e9707a3, replyNumber=0, likeNumber=30, createdTime=2019-12-30, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=371b1e9707a3, moduleTitle=便民服务：全国很大的医院煎药中心正式启用，中药代煎送药到家, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=371b1e9707a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666713, encodeId=99571666e132e, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=三甲医院接待药代先查证件, objectType=article, longId=155951, objectId=11bf155951d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11bf155951d3, replyNumber=0, likeNumber=29, createdTime=2019-06-30, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11bf155951d3, moduleTitle=三甲医院接待药代先查证件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11bf155951d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666745, encodeId=f19c1666e45cb, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=FDA拟修订群体药代动力学指南：医药商需要了解些什么？, objectType=article, longId=181184, objectId=d20a18118420, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d20a18118420, replyNumber=0, likeNumber=36, createdTime=2020-04-11, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d20a18118420, moduleTitle=FDA拟修订群体药代动力学指南：医药商需要了解些什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d20a18118420)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666716, encodeId=59991666e163f, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医药代表备案制来了！一旦“越界”将被列入“黑名单”, objectType=article, longId=157237, objectId=e18d15e23786, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e18d15e23786, replyNumber=0, likeNumber=29, createdTime=2019-11-25, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e18d15e23786, moduleTitle=医药代表备案制来了！一旦“越界”将被列入“黑名单”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e18d15e23786)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666711, encodeId=a5fc1666e112b, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=**降幅96%！“4+7”带量采购报价流出，这些药代要凉了, objectType=article, longId=155307, objectId=e5ef15530e2f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5ef15530e2f, replyNumber=0, likeNumber=23, createdTime=2019-08-01, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5ef15530e2f, moduleTitle=**降幅96%！“4+7”带量采购报价流出，这些药代要凉了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5ef15530e2f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666739, encodeId=22bd1666e392b, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=门诊儿科患者通过鼻腔给予右美托咪定的药代动力学及镇静作用研究, objectType=article, longId=178516, objectId=b2091e85169a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2091e85169a, replyNumber=0, likeNumber=33, createdTime=2019-11-03, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2091e85169a, moduleTitle=门诊儿科患者通过鼻腔给予右美托咪定的药代动力学及镇静作用研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2091e85169a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666734, encodeId=bb891666e34ba, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=Clin Chem：偶尔和长期吸食大麻者模拟驾驶对警惕性和事故风险的影响及其药代动力学-药效学关系, objectType=article, longId=175893, objectId=0c821e5893d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c821e5893d6, replyNumber=0, likeNumber=29, createdTime=2019-11-19, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c821e5893d6, moduleTitle=Clin Chem：偶尔和长期吸食大麻者模拟驾驶对警惕性和事故风险的影响及其药代动力学-药效学关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c821e5893d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666729, encodeId=8c9f1666e29cc, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=JCLA：应用电化学发光法定量测定抗分形多胺单克隆抗体E6011在猴子和人类体内的药代动力学研究, objectType=article, longId=166239, objectId=a52d16623913, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a52d16623913, replyNumber=0, likeNumber=25, createdTime=2019-09-18, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a52d16623913, moduleTitle=JCLA：应用电化学发光法定量测定抗分形多胺单克隆抗体E6011在猴子和人类体内的药代动力学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a52d16623913)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666723, encodeId=19bc1666e2383, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=大洗牌 90万药代已辞职, objectType=article, longId=161076, objectId=75461610e69a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75461610e69a, replyNumber=0, likeNumber=38, createdTime=2019-07-20, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75461610e69a, moduleTitle=大洗牌 90万药代已辞职, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75461610e69a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666728, encodeId=f6f81666e284e, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=刚刚！大批药代被解散, objectType=article, longId=162766, objectId=e9d7162e6699, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9d7162e6699, replyNumber=0, likeNumber=20, createdTime=2019-07-21, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9d7162e6699, moduleTitle=刚刚！大批药代被解散, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9d7162e6699)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666710, encodeId=7cd41666e10ef, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医药代表如何与不同学习风格的医生互动？, objectType=article, longId=153357, objectId=419f15335eab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=419f15335eab, replyNumber=0, likeNumber=33, createdTime=2019-04-27, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=419f15335eab, moduleTitle=医药代表如何与不同学习风格的医生互动？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=419f15335eab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666730, encodeId=58791666e3011, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=GSK调整医药代表薪酬制度，将影响旗下约全球50%销售人员, objectType=article, longId=166876, objectId=de3e1668e65b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de3e1668e65b, replyNumber=0, likeNumber=24, createdTime=2020-01-13, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de3e1668e65b, moduleTitle=GSK调整医药代表薪酬制度，将影响旗下约全球50%销售人员, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de3e1668e65b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666726, encodeId=432a1666e2628, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=大批医药代表工资下降？新机会来了, objectType=article, longId=162083, objectId=b5861620834c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5861620834c, replyNumber=0, likeNumber=22, createdTime=2019-05-16, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5861620834c, moduleTitle=大批医药代表工资下降？新机会来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5861620834c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666735, encodeId=90711666e35a8, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=Blood：VWF清除和FVIII结合的遗传决定因素修饰血友病患者的FVIII药代动力学, objectType=article, longId=176471, objectId=7c801e6471c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c801e6471c5, replyNumber=0, likeNumber=37, createdTime=2020-06-16, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c801e6471c5, moduleTitle=Blood：VWF清除和FVIII结合的遗传决定因素修饰血友病患者的FVIII药代动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c801e6471c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666720, encodeId=7e3f1666e20a8, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=4+7后，还需要药代吗？官方有答复了, objectType=article, longId=160595, objectId=fa88160595e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa88160595e9, replyNumber=0, likeNumber=29, createdTime=2019-12-22, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa88160595e9, moduleTitle=4+7后，还需要药代吗？官方有答复了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa88160595e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药代

2020-05-29

fengyqf (审核中...)

前往app查看评论内容

#药代#

央视曝光！一批医药代表被抓

2020-04-09

fengyqf (审核中...)

前往app查看评论内容

#药代#

全国4+7后，医药代表要跳槽了

2020-08-01

fengyqf (审核中...)

前往app查看评论内容

#药代#

医药代表迎生死局亟待转型

2020-05-03

fengyqf (审核中...)

前往app查看评论内容

#药代#

暗访印度药代购聊城“假药”案的卡博替尼还真是“假药”

2020-02-09

fengyqf (审核中...)

前往app查看评论内容

#药代#

药代离职率高居不下 70%准备转型

2019-05-22

fengyqf (审核中...)

前往app查看评论内容

#药代#

便民服务：全国很大的医院煎药中心正式启用，中药代煎送药到家

2019-12-30

fengyqf (审核中...)

前往app查看评论内容

#药代#

三甲医院接待药代先查证件

2019-06-30

fengyqf (审核中...)

前往app查看评论内容

#药代#

FDA拟修订群体药代动力学指南：医药商需要了解些什么？

2020-04-11

fengyqf (审核中...)

前往app查看评论内容

#药代#

医药代表备案制来了！一旦“越界”将被列入“黑名单”

2019-11-25

fengyqf (审核中...)

前往app查看评论内容

#药代#

**降幅96%！“4+7”带量采购报价流出，这些药代要凉了

2019-08-01

fengyqf (审核中...)

前往app查看评论内容

#药代#

门诊儿科患者通过鼻腔给予右美托咪定的药代动力学及镇静作用研究

2019-11-03

fengyqf (审核中...)

前往app查看评论内容

#药代#

Clin Chem：偶尔和长期吸食大麻者模拟驾驶对警惕性和事故风险的影响及其药代动力学-药效学关系

2019-11-19

fengyqf (审核中...)

前往app查看评论内容

#药代#

JCLA：应用电化学发光法定量测定抗分形多胺单克隆抗体E6011在猴子和人类体内的药代动力学研究

2019-09-18

fengyqf (审核中...)

前往app查看评论内容

#药代#

大洗牌 90万药代已辞职

2019-07-20

fengyqf (审核中...)

前往app查看评论内容

#药代#

刚刚！大批药代被解散

2019-07-21

fengyqf (审核中...)

前往app查看评论内容

#药代#

医药代表如何与不同学习风格的医生互动？

2019-04-27

fengyqf (审核中...)

前往app查看评论内容

#药代#

GSK调整医药代表薪酬制度，将影响旗下约全球50%销售人员

2020-01-13

fengyqf (审核中...)

前往app查看评论内容

#药代#

大批医药代表工资下降？新机会来了

2019-05-16

fengyqf (审核中...)

前往app查看评论内容

#药代#

Blood：VWF清除和FVIII结合的遗传决定因素修饰血友病患者的FVIII药代动力学

2020-06-16

fengyqf (审核中...)

前往app查看评论内容

#药代#

4+7后，还需要药代吗？官方有答复了

2019-12-22

科室
- - 订阅+
  - 更多科室
工具
服务